-
Study characteristics.
*other than SAA: MAA or not reported degree of severity. †other than first-line MRD: second-line HSCT, first-line mismatched related HSCT, first-line- unrelated HSCT.‡Fouladi... -
Depression among epileptic patients and its association with drug therapy in ...
BackgroundDespite the high prevalence of epilepsy in sub-Saharan Africa and the established relationship between depression and epilepsy, the extent of comorbid epilepsy and... -
Comparative 3-year mean healthcare and societal costs (2011–12 prices) betwee...
Comparative 3-year mean healthcare and societal costs (2011–12 prices) between groups of patients with positive and negative results on HADS (cut-off 12+) and CISR (any CMD). -
Percentage of parents of children with and without IDD scoring above clinical...
Percentage of parents of children with and without IDD scoring above clinical cut-off scores for moderate anxiety. -
Model predicting future reporting of symptoms according to baseline measure.
Model predicting future reporting of symptoms according to baseline measure. -
r37980778c78--420145cde85f44ee5523b322cd2c8b86
Severity of depressive disorders in HIV-infected adults evaluated by the Beck Depression Inventory (BDI). -
Associations of PHQ-9 scores with socio-demographic characteristics and sexua...
Associations of PHQ-9 scores with socio-demographic characteristics and sexual identity. -
Sensitivity, specificity, and distance to (0,1) point of each cut-off point o...
Sensitivity, specificity, and distance to (0,1) point of each cut-off point on the HADS. -
r37980778c78--ba104ba435912fa8d3635de6323b7fe3
Initial treatment selection (TS) and actual treatment initialization (TI) in %. -
Patients characteristics.
Legend to Table 2 to 7B: The CTL epitopes that should be recognized according to the HLA alleles are defined using the HXB2 reference. The observed corresponding epitopes in the... -
r37980778c78--847941c17a5d488beb44eeb90fb87aba
Results from the final multivariate model for predictor of PND, using Multivariate Adjusted Odds Ratios (OR) and 95% Confidence Intervals (95% CI). -
Primary end-point of treatment delay/ dose reduction/ drug change or hospital...
Primary end-point of treatment delay/ dose reduction/ drug change or hospitalisation in patients receiving vitamin B12 and folate <7 days and ≥7 days. -
Adjusted Hazard Ratio (aHR) with 95% Confidence Intervals (CI) for Explanator...
Adjusted Hazard Ratio (aHR) with 95% Confidence Intervals (CI) for Explanatory Variables of the First Recurrence of Current Depressive Symptoms among HIV-positive Participants...
